We are live on ! Find out more
OCRX

Ocera Therapeutics, Inc.
OCRX

Delisted

OCRX was delisted on the 8th of December, 2017.

Back to rankings

18 hedge funds and large institutions have $44.6M invested in Ocera Therapeutics, Inc. in 2013 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

660% more capital invested

Capital invested by funds: $5.87M → $44.6M (+$38.7M)

400% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 2

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

80% more funds holding

Funds holding: 10 → 18 (+8)

Holders
18
Holders Change
+8
Holders Change %
+80%
% of All Funds
0.52%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
10
Increased
5
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VM
VHCP Management
New York
+$6.57M
2
QF
QVT Financial
New York
+$5.92M
3
GPP
Great Point Partners
Connecticut
+$4.93M
4
RCM
RA Capital Management
Massachusetts
+$4.16M
5
DM
Deerfield Management
New York
+$1.97M

Top Sellers

Rank Fund Capital Flow
1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$11K
2
U
UBS
Switzerland
-$3K
3
TRCT
Tower Research Capital (TRC)
New York
-$1.72K
Name Holding Trade Value Shares
Change 		Change in
Stake
VM
1
VHCP Management
New York
$9.14M +$6.57M +703,730 New
QF
2
QVT Financial
New York
$8.64M +$5.92M +633,357 +663%
RCM
3
RA Capital Management
Massachusetts
$8.6M +$4.16M +445,697 +206%
GPP
4
Great Point Partners
Connecticut
$6.86M +$4.93M +527,797 New
Jennison Associates
5
Jennison Associates
New York
$3.09M – – –
DM
6
Deerfield Management
New York
$2.74M +$1.97M +211,119 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$2.04M +$419K +44,818 +40%
GTC
8
Ghost Tree Capital
New York
$974K +$701K +75,000 New
DCM
9
DAFNA Capital Management
California
$821K +$517K +55,329 +701%
SM
10
Sabby Management
Florida
$779K +$560K +59,984 New
Deutsche Bank
11
Deutsche Bank
Germany
$387K +$83.8K +8,969 +43%
SFM
12
Sphera Funds Management
Israel
$193K +$139K +14,881 New
Renaissance Technologies
13
Renaissance Technologies
New York
$181K +$130K +13,949 New
Morgan Stanley
14
Morgan Stanley
New York
$154K +$111K +11,886 New
TRCT
15
Tower Research Capital (TRC)
New York
$8K -$1.72K -184 -23%
California Public Employees Retirement System
16
California Public Employees Retirement System
California
$2K – – –
Bank of America
17
Bank of America
North Carolina
$1K +$374 +40 New
Barclays
18
Barclays
United Kingdom
$1K +$785 +84 New
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
– -$11K -1,300 Closed
U
20
UBS
Switzerland
– -$3K -389 Closed

OCRX Hedge Fund Activity: Q4 2013 in Review

18 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Ocera Therapeutics, Inc. (OCRX) for Q4 2013, worth a combined $44.6M — up 660% from $5.87M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new OCRX positions and 2 closed out — a net gain of 8 holders — while 5 added to existing stakes and 1 trimmed.

The largest buyer was VHCP Management, opening a new position worth an estimated $6.57M. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $11K sold.

  • 18 institutional investors held Ocera Therapeutics, Inc. (OCRX) as of Q4 2013, up from 10 in Q3 2013.
  • Funds reported $44.6M of Ocera Therapeutics, Inc. stock for Q4 2013, up 660% quarter-over-quarter.
  • 10 funds opened new Ocera Therapeutics, Inc. positions in Q4 2013 and 2 closed out, a net change of +8 holders.
  • The largest Ocera Therapeutics, Inc. buyer in Q4 2013 was VHCP Management, an estimated $6.57M added.
  • The largest Ocera Therapeutics, Inc. seller in Q4 2013 was Dimensional Fund Advisors, an estimated $11K sold.

Based on aggregated 13F filings for Q4 2013.